Evaluation of the new NG OligoGen kit for the diagnosis of Neisseria gonorrhoeae: comparison with cobas 4800 assay.
Samples from an STD clinic with a prevalence of NG infection of 4.98% (of them, 52% between MSM patients) were used for this study.
Statistical data confirmed the usefulness and reliable results of this new assay.
As cobas 4800 assay, screening tests for N. gonorrhoeae do not require a second test to confirm.